换一批
换一批Discovery and validation of a personalized risk predictor for incident tuberculosis in low transmission settings.
作者：
Rishi K,Gupta [1]
;
Claire J,Calderwood [1]
;
Alexei,Yavlinsky [2]
;
Maria,Krutikov [1]
;
Matteo,Quartagno [3]
;
Maximilian C,Aichelburg [4]
;
Neus,Altet [5]
;
Roland,Diel [6]
;
Claudia C,Dobler [7]
;
Jose,Dominguez [8]
;
Joseph S,Doyle [9]
;
Connie,Erkens [10]
;
Steffen,Geis [11]
;
Pranabashis,Haldar [12]
;
Anja M,Hauri [13]
;
Thomas,Hermansen [14]
;
James C,Johnston [15]
;
Christoph,Lange [16]
;
Berit,Lange [17]
;
Frank,van Leth [18]
;
Laura,Muñoz [19]
;
Christine,Roder [20]
;
Kamila,Romanowski [21]
;
David,Roth [22]
;
Martina,Sester [23]
;
Rosa,Sloot [24]
;
Giovanni,Sotgiu [25]
;
Gerrit,Woltmann [26]
;
Takashi,Yoshiyama [24]
;
Jean-Pierre,Zellweger [27]
;
Dominik,Zenner [28]
;
Robert W,Aldridge [29]
;
Andrew,Copas [14]
;
Molebogeng X,Rangaka [15]
;
Marc,Lipman [21]
;
Mahdad,Noursadeghi [21]
;
Ibrahim,Abubakar [24]
作者单位：
Institute for Global Health, University College London, London, UK.
[1]
Institute of Health Informatics, University College London, London, UK.
[2]
MRC Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, UK.
[3]
Department of Dermatology, Sozialmedizinisches Zentrum Ost-Donauspital, Vienna, Austria.
[4]
Unitat de Tuberculosis, Hospital Universitari Vall d'Hebron-Drassanes, Barcelona, Spain.
[5]
Unitat de TDO de la Tuberculosis 'Servicios Clínicos', Barcelona, Spain.
[6]
Institute for Epidemiology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
[7]
Lung Clinic Grosshansdorf, Airway Research Center North (ARCN), Großhansdorf, Germany.
[8]
Institute for Evidence-Based Healthcare, Faculty of Health Sciences and Medicine, Bond University, Gold Coast, Queensland, Australia.
[9]
Department of Respiratory Medicine, Liverpool Hospital, Sydney, Australia.
[10]
Institut d'Investigació Germans Trias i Pujol, Badalona, Barcelona, Spain.
[11]
CIBER Enfermedades Respiratorias, Badalona, Barcelona, Spain.
[12]
Universitat Autònoma de Barcelona, Badalona, Barcelona, Spain.
[13]
Department of Infectious Diseases, The Alfred and Monash University, Melbourne, Australia.
[14]
Disease Elimination Program, Burnet Institute, Melbourne, Australia.
[15]
KNCV Tuberculosis Foundation, The Hague, The Netherlands.
[16]
Institute for Medical Microbiology and Hospital Hygiene, Philipps University of Marburg, Marburg, Germany.
[17]
Respiratory Biomedical Research Centre, Institute for Lung Health, Department of Respiratory Sciences, University of Leicester, Leicester, UK.
[18]
Hesse State Health Office, Dillenburg, Germany.
[19]
International Reference Laboratory of Mycobacteriology, Statens Serum Institut, Copenhagen, Denmark.
[20]
British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada.
[21]
Division of Clinical Infectious Diseases, Research Center Borstel, Borstel, Germany.
[22]
German Center for Infection Research (DZIF), Clinical Tuberculosis Center, Borstel, Germany.
[23]
Tuberculosis Network European Trials Group (TBnet), Borstel, Germany.
[24]
Department of Medicine, Karolinska Institute, Stockholm, Sweden.
[25]
Department of Epidemiology, Helmholtz Centre for Infection Research, Braunschweig, Germany.
[26]
Amsterdam Institute for Global Health and Development, Amsterdam, the Netherlands.
[27]
Department of Global Health, Amsterdam University Medical Centres, Amsterdam, the Netherlands.
[28]
Department of Clinical Sciences, University of Barcelona, Barcelona, Spain.
[29]
Department of Transplant and Infection Immunology, Saarland University, Homburg, Germany.
[30]
Department of Paediatrics and Child Health, Desmond Tutu TB Centre, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
[31]
Clinical Epidemiology and Medical Statistics Unit, Department of Medical, Surgical and Experimental Sciences, Uniiversity of Sassari, Sassari, Italy.
[32]
Research Institute of Tuberculosis, Tokyo, Japan.
[33]
Swiss Lung Association, Berne, Switzerland.
[34]
Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
[35]
Division of Epidemiology and Biostatistics, School of Public Health, University of Cape Town, Cape Town, South Africa.
[36]
UCL-TB and UCL Respiratory, University College London, London, UK.
[37]
Royal Free London NHS Foundation Trust, London, UK.
[38]
Division of Infection & Immunity, University College London, London, UK.
[39]
Institute for Global Health, University College London, London, UK. i.abubakar@ucl.ac.uk.
[40]
主题词
青少年(Adolescent);成年人(Adult);儿童(Child);女(雌)性(Female);人类(Humans);潜伏性结核(Latent Tuberculosis);男(雄)性(Male);结核分枝杆菌(Mycobacterium tuberculosis);预后(Prognosis);危险因素(Risk Factors);结核菌素试验(Tuberculin Test);结核(Tuberculosis)
DOI
10.1038/s41591-020-1076-0
PMID
33077958
发布时间
2023-08-16
- 浏览2
Nature medicine
Nature medicine
1941-1949页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
